絞り込み

16610

広告

Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.

著者 Slaughter JL , Stenger MR , Reagan PB , Jadcherla SR
J Pediatr.2016 Apr 21 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (12view , 0users)

Full Text Sources

Medical

To determine treatment frequency and duration of histamine-2 receptor antagonist (H2RA)/proton pump inhibitor (PPI) use among infants hospitalized within US children's hospital neonatal intensive care units and evaluate diagnoses/demographic factors associated with use.
PMID: 27131401 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード